Development

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Taste-masking can be of significant importance in ensuring success of a drug product, particularly those targeted to pediatric or geriatric populations.

Masking Taste: A Key Attribute to Success

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.

Factoring Stability in the Biologic Drug Mix

Risk-based decision-making is impacting all aspects of manufacturing quality from raw material supply to facility inspections. 

Tracking API Quality During a Pandemic

Supply chain traceability is essential in the manufacture of APIs to assure safety and quality.

Tracing the Supply Chain

Understanding and overcoming excipient variation are crucial for successful continuous processes.

Key Ingredients Needed to Drive the Success of Continuous Manufacturing 

CordenPharma added a 3000-L solid-phase peptide synthesis vessel to its GMP API facility in Boulder, CO.

CordenPharma Increases US Peptide Manufacturing Capacity

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Can RNA Simplify Gene Therapy Development?

The company has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy for the treatment of COVID-19 in patients at high risk of declining health due to age or comorbid conditions.

Cascade Chemistry Selected to Produce API for COVID-19 Treatment

The correct mix of excipients is crucial to the success of fast dissolving/orally disintegrating dosage forms.

Formulating for Convenience and Compliance

Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks? 

APIs and Excipients